Related by context. Frequent words. (Click for all words.) 59 Mark A. Sirgo 58 Plachetka 58 David Aviezer 56 George Scangos 56 Matthew Emmens 55 Eamonn Hobbs 53 Aegera 52 Inc. NASDAQ EXEL 52 Inc. Nasdaq BIOD 52 Geoffrey Porges 51 MultiCell Technologies 50 Joel Sendek 50 Neurobiological Technologies 50 Inc. Nasdaq EXEL 50 ImmunoCellular Therapeutics 49 Simeonidis 49 Neurosearch 49 NASDAQ CYPB 49 OGXI 49 Amorcyte 49 Patrick J. Balthrop 49 Kevin Buchi 49 Neogenix 49 Kauffman MD Ph.D. 49 MyVax 48 NASDAQ ARRY 48 TOLAMBA 48 TapImmune 48 NASDAQ SLXP today 48 Randal Mills 48 Takashi Shoda 48 IDEV 48 Vaccinex 48 Inc Therapeutic Competitors 48 Ligand Pharmaceuticals Incorporated 47 analyst Mark Schoenebaum 47 cabozantinib 47 Biegelsen 47 Bret Holley 47 Marc Cluzel 46 TSX COM 46 JP Garnier 46 HealthCor 46 Nasdaq ALKS 46 Genz # 46 Nasdaq OSIP 46 PharmaFrontiers 46 Eyetech Pharmaceuticals 46 NASDAQ MYGN 46 Immunosyn 46 Nasdaq VRTX 45 Callisto Pharmaceuticals 45 trastuzumab DM1 T DM1 45 analyst Larry Biegelsen 45 Affymax Inc. 45 Leerink 45 analyst Jami Rubin 45 Kantarjian 45 Jon LeCroy 45 Tao Levy 44 analyst Glenn Reicin 44 Alzhemed 44 Opko 44 Inc. Nasdaq ACOR 44 Aberman 44 plc NASDAQ AMRN 44 Jason Gurda 44 unblind 44 Steven Harr 44 ADVR 43 fullyear 43 PreGen Plus 43 DeKosky 43 ZIOPHARM Oncology Inc. 43 Inc. NASDAQ MIPI 43 Immunex Corporation 43 normalized FFO 43 ABSORB trial 43 Cristofanilli 43 Desmond Hellmann 43 SYMMETRY trial 42 http:/www.keryx.com 42 Microbia 42 Neuro Hitech 42 Acumen BioFin Rodman 42 phase IIa 42 iroxanadine 42 Soon Shiong 42 Pi Sunyer 42 SUCCEED trial 42 telebriefing 42 Funtleyder 42 NASDAQ BMTI 41 teriflunomide 41 initiate Phase IIb 41 told BioWorld Today 41 Ridker 41 NASDAQ GEOI 41 ICON plc 41 NYSE Euronext PHARM 41 NLX P#